Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Skin reactions from cancer treatments might predict how well the treatments work.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Nanospanlastics are effective in targeted drug delivery for chronic diseases, improving skin conditions, treating hair loss, and increasing drug absorption.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Angelica sinensis and Tetrapanax papyrifer are common in Taiwanese TCM for lactation, with potential anticancer benefits.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Aesthetic treatments can safely improve cancer patients' quality of life with oncologist approval.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

TLR7-based compounds may help manage chemotherapy-induced hair loss.